Expression of vascular endothelial growth factor receptors in smooth muscle cells

被引:190
作者
Ishida, A
Murray, J
Saito, Y
Kanthou, C
Benzakour, O
Shibuya, M
Wijelath, ES
机构
[1] Hope Heart Inst, Dept Mol Biol, Seattle, WA 98122 USA
[2] Thrombosis Res Inst, Mol Cell Biol Lab, London SW3 6LR, England
[3] Univ Tokyo, Inst Med Sci, Dept Genet, Tokyo, Japan
关键词
D O I
10.1002/jcp.1121
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Vascular Endothelial Growth Factor (VEGF) has been typically considered to be an endothelial-specific growth factor. However, it was recently demonstrated that VEGF can interact with non endothelial cells. In this study, we tested whether vascular smooth muscles cells (VSMCs) can express VEGF receptors, such as flk-1, flt-1, and neuropilin (NP)-1, and respond to VEGF in vitro. In cultured VSMCs, flk-1 and flt-1 expression was inversely related to cell density. The expression of flk-1 was down-regulated with increasing passage numbers. However, NP-1 levels were not affected by cell density or passage numbers. Flk-1, Flt-1, and NP-1 protein levels were confirmed by Western Blotting. Although the functional mature form of Flk-1 protein is expressed at low levels in VSMCs, phosphorylation of Flk-1 following VEGF(165) stimulation was still observed. SMCs migrated significantly in response to VEGF(165) and VEGF-E, whereas Placenta Growth Factor (PIGF) induced migration only at higher concentrations. Since VEGF-E is a specific activator of flk-1 while PIGF specifically activates only flt-1, SMC migration induced by VEGF(165) is likely to be mediated primarily through the flk-1 receptor. VSMCs did not significantly proliferate in response to VEGF(165), PIGF, and VEGF-E. In conclusion, our studies demonstrate the presence of VEGF receptors on VSMCs that are functional. These studies also indicate that in vivo, VEGF may play a role in modulating the response of VSMCs.
引用
收藏
页码:359 / 368
页数:10
相关论文
共 39 条
[1]  
ARCINIEGAS E, 1992, J CELL SCI, V103, P521
[2]   Isolation of putative progenitor endothelial cells for angiogenesis [J].
Asahara, T ;
Murohara, T ;
Sullivan, A ;
Silver, M ;
vanderZee, R ;
Li, T ;
Witzenbichler, B ;
Schatteman, G ;
Isner, JM .
SCIENCE, 1997, 275 (5302) :964-967
[3]   Vascular development: Cellular and molecular regulation [J].
Beck, L ;
DAmore, PA .
FASEB JOURNAL, 1997, 11 (05) :365-373
[4]  
Benzakour O, 1996, THROMB HAEMOSTASIS, V75, P854
[5]   INDIRECT ANGIOGENIC CYTOKINES UP-REGULATE VEGF AND BFGF GENE-EXPRESSION IN VASCULAR SMOOTH-MUSCLE CELLS, WHEREAS HYPOXIA UP-REGULATES VEGF EXPRESSION ONLY [J].
BROGI, E ;
WU, TG ;
NAMIKI, A ;
ISNER, JM .
CIRCULATION, 1994, 90 (02) :649-652
[6]   Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression [J].
Brogi, E ;
Schatteman, G ;
Wu, T ;
Kim, EA ;
Varticovski, L ;
Keyt, B ;
Isner, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (02) :469-476
[7]  
Brown LF, 1997, LAB INVEST, V76, P245
[8]   Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis [J].
Carmeliet, P ;
Lampugnani, MG ;
Moons, L ;
Breviario, F ;
Compernolle, V ;
Bono, F ;
Balconi, G ;
Spagnuolo, R ;
Oosthuyse, B ;
Dewerchin, M ;
Zanetti, A ;
Angellilo, A ;
Mattot, V ;
Nuyens, D ;
Lutgens, E ;
Clotman, F ;
de Ruiter, MC ;
Gittenberger-de Groot, A ;
Poelmann, R ;
Lupu, F ;
Herbert, JM ;
Collen, D ;
Dejana, E .
CELL, 1999, 98 (02) :147-157
[9]   Immunohistochemical expression of vascular endothelial growth factor vascular permeability factor in atherosclerotic intimas of human coronary arteries [J].
Chen, YX ;
Nakashima, Y ;
Tanaka, K ;
Shiraishi, S ;
Nakagawa, K ;
Sueishi, K .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (01) :131-139
[10]  
Couper LL, 1997, CIRC RES, V81, P932